PedAM
Pediatric Disease Annotations & Medicines
| Disease | thrombocytopenia |
| Phenotype | C0023418|leukemias |
| Sentences | 2 |
| PubMedID- 26501980 | Since cd22 is a b-lymphocyte-restricted phosphoglycoprotein [184], inotuzumab ozogamicin has been clinically examined in b-cell leukemias and lymphomas with reversible thrombocytopenia as the main toxicity observed. |
| PubMedID- 24413066 | Most frequent presentations concerned neutropenia and/or anemia (62%), whereas some t-lgl leukemias presented with neutropenia plus thrombocytopenia (12%). |
Page: 1